The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 kinase, for use in the diagnosis, prevention and/or treatment of LRRK2 -kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent. Finally, the present invention also relates to new macrocyclic compounds.
本发明涉及大环化合物以及含有作为激酶
抑制剂,特别是LRRK2激酶
抑制剂的化合物的组合物,用于诊断、预防或治疗与LRRK2激酶相关的疾病。此外,本发明还提供了使用所述化合物的方法,例如作为药物或诊断剂。最后,本发明还涉及新的大环化合物。